Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02JVI
|
|||
Former ID |
DNC004657
|
|||
Drug Name |
1-Benzooxazol-2-yl-6-phenyl-hexan-1-one
|
|||
Synonyms |
CHEMBL366907; 1-Benzooxazol-2-yl-6-phenyl-hexan-1-one
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H19NO2
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CCCCCC(=O)C2=NC3=CC=CC=C3O2
|
|||
InChI |
1S/C19H19NO2/c21-17(19-20-16-12-7-8-14-18(16)22-19)13-6-2-5-11-15-9-3-1-4-10-15/h1,3-4,7-10,12,14H,2,5-6,11,13H2
|
|||
InChIKey |
PCLBCMUYLOBYMW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.